Log In
BCIQ
Print this Print this
 

Trokendi XR, topiramate (formerly SPN-538)

  Manage Alerts
Collapse Summary General Information
Company Supernus Pharmaceuticals Inc.
DescriptionExtended release formulation of topiramate
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEpilepsy
Indication DetailsTreat epilepsy
Regulatory Designation U.S. - Standard Review (Treat epilepsy)
PartnerAequus Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/15/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today